Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




A Nanofiber Bandage with Minimal Adhesion Encourages Rapid Clotting

By HospiMedica International staff writers
Posted on 28 Jan 2020
A new study unveils a bandage made of superhydrophobic (SHP) hemostatic nanofiber composites that helps blood clot faster and eases detachment after clot shrinkage.

Developed at the Swiss Federal Institute of Technology (ETH; Zurich, Switzerland) and the National University of Singapore (NUS, Singapore), the new bandage is based on a SHP surface with immobilized carbon nanofibers (CNFs), which promote fast fibrin growth and convey anti-bacterial properties. More...
The hemostatic surface simultaneously promotes fast clotting with no blood loss, and due to the presence of micro-air pockets within the blood-substrate contact area, there is minimal contact between the clot and the SHP CNF patch, leading to natural detachment after clot maturation and shrinkage.

To verify the features in vivo, experiments were performed on rats with the back-bleeding model. While normal gauze absorbed blood and left behind an open wound, no blood was observed seeping through the CNF gauze, demonstrating excellent blood-repelling property. Further, a darkened gel-like clot was observed under the CNF gauze after three minutes, which properly sealed the wound, as opposed to the wound that remained open under the control gauze. The average blood loss was just 1.5% of that for the normal gauze. The study was published on December 5, 2019, in Nature Communications.

“With the new superhydrophobic material, we can avoid reopening the wound when changing the bandage,” said study co-author Athanasios Milionis, PhD, of ETH. “Reopening wounds is a major problem, primarily because of the risk of infection, including from dangerous hospital germs, a risk that is especially high when changing bandages.”

The conventional method to deal with bleeding is mechanically pressing the wound with a cotton gauze, which causes unnecessary blood loss and gauze adhesion onto the wound. Blood absorbed in the gauze forms a solid clot-gauze composite, forced peeling of which often tears the wound and causes secondary bleeding and pain. This makes it difficult to replace the old wound dressing without causing secondary infections or hemorrhage, in procedures ranging from common wounds to surgery, and to the extreme case of hemophilic patients, where excessive bleeding will occur before coagulation.

Related Links:
Swiss Federal Institute of Technology
National University of Singapore



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Resorbable Bovine Collagen Membrane
GenDerm
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: The findings suggest that hematopoietic cell transplantation may benefit patients with Shwachman-Diamond syndrome soon after high-risk features are detected, before advanced malignancy develops. (Image Credit: Shutterstock)

Early Stem Cell Transplantation May Improve Survival in Rare Inherited Bone Marrow Disorder

Shwachman-Diamond syndrome (SDS) is a rare inherited bone marrow disorder that can progress to severe hematologic disease. More than 90% of affected children survive beyond age 20, but fewer than 30% live... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.